Podcasts about guidelines

This week, Ryan recounts recent skywatch experiences with 700–1,000 people at Contact in the Desert 2025, along with extraordinary sightings shared with Aaron Kitcher and his partner, Helen (Bledsoe Said So Episode 212). He also offers a vivid recap of his time at the Monroe Institute's Guidelines program, a transformative five-day journey designed to help you turn inward, heighten your intuitive abilities, and connect with your inner guidance.

This week, Dr. Kahn breaks down the latest guidelines for preventing and treating high blood pressure. He reviews the top 10 lessons from an important new medical article and encourages every listener to own a home blood pressure cuff, use it regularly, and aim for readings under 120/80. Along the way, he also discusses new research on Lipoprotein(a) myths, EMF exposure, cystatin C kidney lab tests, the Fasting Mimicking Diet and its impact on kidney health (prolonlife.com/drkahn), and the role of vitamin C in overall wellness. Thanks to igennus.com for supporting the show, with a special discount available using the code DrKahn.

#274 Growth | In this episode, Dave is joined by Sean Lane, Founding Partner at BeaconGTM and RevOps expert, to talk about scaling RevOps in B2B. With over a decade of experience at Drift and other B2B SaaS companies, Sean shares actionable tips for marketers looking to align operations with business goals.Dave and Sean cover:How to build alignment between sales, marketing, and opsWhy early-stage companies must align operational complexity with their growth maturityHow continuous planning helps marketing and ops teams stay agile as business challenges come upTimestamps(00:00) - - Intro to Sean (07:11) - - Going From Founder Led Sales to Having A Professional GTM (09:52) - - How Ops Bridges Business Goals (13:42) - - How To Align Sales, Marketing, and Operations (17:51) - - Why You Need A Clear Marketing Strategy (20:17) - - How To Build A Partnership Between Marketing and Operations (26:41) - - Guidelines for long term vs short term budgeting and planning (32:19) - - Marketing's Role At The Bottom Of The Funnel (37:14) - - How To Get “Hand-raisers” For Your Product In The Customer Journey (41:06) - - Do Engaged Accounts Measure The Success Of Marketing? (42:56) - - Sean's Podcast ROI (45:12) - - AI Use Cases In Ops (50:14) - - How To Hire A Good Ops Person (53:42) - - Closing Remarks Send guest pitches and ideas to hi@exitfive.comJoin the Exit Five Newsletter here: https://www.exitfive.com/newsletterCheck out the Exit Five job board: https://jobs.exitfive.com/Become an Exit Five member: https://community.exitfive.com/checkout/exit-five-membership***Today's episode is brought to you by Walnut.Why are we pouring all this effort into marketing just to push buyers to a “request a demo” or “contact sales” button?Come on, today's buyers don't want to talk to sales right away. They want to explore your product themselves, see how it works, and understand its value before booking a meeting.That's where Walnut comes in.Walnut empowers marketers and GTM teams to create interactive, self-guided product experiences in minutes. Embed these experiences on your site, in emails, or anywhere in your funnel to let buyers engage on their terms, from awareness to close and beyond. That's the beauty of Walnut - you're getting a platform that your sales and CS colleagues can use to showcase the product too.And the best part? You get real intent data—see which features prospects love, where they drop off, and what's actually driving pipeline. Demo Qualified Leads are the new MQL.Over 500 companies, like Adobe and NetApp, use Walnut to drive 2-3x higher website conversion rates and 7 figures in pipeline on a yearly basis. So do you want to drive more leads, shorten sales cycles, and actually show your product instead of hiding it behind another typical B2B CTA? Go check out Walnut.io. And if you tell them Dave from Exit 5 sent you, they'll build out your first demo for free!

Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease by Gastroenterology Learning Network

LISTEN: On the Friday, Aug. 15 edition of Georgia Today: Leaders from the Atlanta-based CDC will be part of a reinstated vaccine task force; the EPA announces new guidance for farmers on a controversial herbicide; and a new documentary series profiles the Atlanta cultural institution known as Magic City.  

SCOTUS has allowed Mississippi to enforce a law that impacts how minors use social media. We tell you why there are a mix of high hopes and skepticism around President Donald Trump's summit tomorrow. Texas Democrats signal they're ready to work with state Republicans again. President Trump's crackdown on DC's homeless population has begun. Plus, get ready for a bit more aggressive approach to high blood pressure. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In our conversation, Dr Akhave discussed the addition of toripalimab (Loqtorzi), a PD-1 inhibitor, to the NCCN Guidelines following its launch in the United States. Supported by data from the phase 3 JUPITER-02 trial (NCT03581786), toripalimab is now incorporated into frontline therapy for patients with recurrent metastatic or de novo metastatic Epstein–Barr virus (EBV)–positive NPC, in combination with gemcitabine and cisplatin. He explained how this regimen has produced substantial improvements in progression-free survival (PFS), nearly tripling median PFS compared with chemotherapy alone, while maintaining a manageable safety profile.

We've got something a little bit different for you today. Some people may remember the wonderful episode about dealing with Uncertainty we did way back in 2020 with  GP, Primary Care Educator and Author Dr Avril Danczak. It was such an important episode in our careers and I know helped many others. We wanted to share the news that Avril is doing brilliant podcasting work with the ever pragmatic Professor James McCormack. Their podcast Contented clinician, people may have already found, but we thought it would be useful to post one here to signpost listeners to their good work. Welcome to Episode 6 of The Contented Clinician Podcast! Dr Avril Danczak and Professor James McCormack created The Contented Clinician Podcast to help clinicians find more joy and satisfaction in your practice by blending a collective of real-world experience, common sense, and the best available evidence. So, if you're looking to make your clinical practice more fulfilling and sustainable, join us and our inspiring network of clinicians as we explore new perspectives and effective strategies to reshape the way you think about your work. The Case: Dr. Ashville is currently training to become a family physician. One day, they receive a phone call from a frustrated patient named Jane Brown. Jane had received a message stating: “As your cardiovascular risk is now 10%, it is recommended you take a statin medication.” She is upset because no one had a proper conversation with her about starting a new prescription. Her main concern is: “How likely am I to actually benefit from this treatment? Is it really worth it?” Dr. Ashville realizes they had simply been following a protocol and isn't entirely sure how to answer Jane's question. Wanting to better understand how to provide more balanced information, Dr. Ashville decides to discuss the issue with the clinician supervising their medical education. Resources: GP Evidence: https://gpevidence.org/   James McCormack: Doing statistics can be difficult but understanding them can be fairly simple: https://www.sensible-med.com/p/doing-statistics-can-be-difficult ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback Email us at: primarycarepodcasts@gmail.com ___ This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

The guidelines are in and the myths are out. In this episode of the BackTable Podcast, Dr. Suzette Sutherland hosts Dr. Melissa Kaufman and Dr. Giulia Ippolito to discuss the new 2025 AUA/SUFU guidelines on genitourinary syndrome of menopause (GSM). ---SYNPOSISThe doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses concerns related to hormone therapy and cancer risks. Additionally, the doctors cover non-hormonal interventions, the role of vaginal moisturizers and lubricants, and the use of vaginal lasers. The importance of follow-up and ongoing patient education is also highlighted. The conversation aims to equip clinicians with the knowledge to better manage GSM and improve patient outcomes.---TIMESTAMPS00:00 - Introduction 01:35 - Overview of the 2025 AUA/SUFU Guidelines02:27 - Guideline Development Process05:48 - Categories of Guidelines07:03 - Understanding GSM: Symptoms and Diagnosis10:28 - Patient Education and Shared Decision Making15:22 - Hormonal Interventions and Safety Concerns17:17 - Local Vaginal Estrogen: Recommendations and Usage23:12 - Compounded Estrogens and Alternative Therapies25:48 - Understanding Estrogen Dosage Forms26:11 - Introduction to DHEA and Its Benefits27:15 - Exploring Ospemifene as an Alternative28:05 - Guidelines for Treating GSM Symptoms30:11 - The Role of Vaginal Estrogen in UTI Prevention33:01 - Non-Hormonal Interventions for GSM35:39 - Laser Treatments for GSM39:59 - Addressing Cancer Risks with Vaginal Estrogen44:48 - Endometrial Surveillance and Follow-Up49:14 - Advocating for Vaginal Estrogen Use51:13 - Conclusion and Final Thoughts

The guidelines are in and the myths are out. In this episode of the BackTable Podcast, Dr. Suzette Sutherland hosts Dr. Melissa Kaufman and Dr. Giulia Ippolito to discuss the new 2025 AUA/SUFU guidelines on genitourinary syndrome of menopause (GSM). ---SYNPOSISThe doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses concerns related to hormone therapy and cancer risks. Additionally, the doctors cover non-hormonal interventions, the role of vaginal moisturizers and lubricants, and the use of vaginal lasers. The importance of follow-up and ongoing patient education is also highlighted. The conversation aims to equip clinicians with the knowledge to better manage GSM and improve patient outcomes.---TIMESTAMPS00:00 - Introduction 01:35 - Overview of the 2025 AUA/SUFU Guidelines02:27 - Guideline Development Process05:48 - Categories of Guidelines07:03 - Understanding GSM: Symptoms and Diagnosis10:28 - Patient Education and Shared Decision Making15:22 - Hormonal Interventions and Safety Concerns17:17 - Local Vaginal Estrogen: Recommendations and Usage23:12 - Compounded Estrogens and Alternative Therapies25:48 - Understanding Estrogen Dosage Forms26:11 - Introduction to DHEA and Its Benefits27:15 - Exploring Ospemifene as an Alternative28:05 - Guidelines for Treating GSM Symptoms30:11 - The Role of Vaginal Estrogen in UTI Prevention33:01 - Non-Hormonal Interventions for GSM35:39 - Laser Treatments for GSM39:59 - Addressing Cancer Risks with Vaginal Estrogen44:48 - Endometrial Surveillance and Follow-Up49:14 - Advocating for Vaginal Estrogen Use51:13 - Conclusion and Final Thoughts

Power—especially in so-called “high society”—is inherently self-protective. The wealthy and well-connected operate in a closed loop where influence is currency, and the stakes are too high to let one of their own fall. Scandals are contained, evidence is buried, and narratives are rewritten through media allies, legal teams, and political connections. When someone inside this sphere is accused of wrongdoing, the machinery of protection activates instantly—redirecting blame, discrediting accusers, and leveraging every institution that can be bent to their will. It's not about innocence or guilt—it's about preserving the brand, the network, and the status that their entire existence depends on.In high society, reputation isn't just social capital—it's armor. That armor is reinforced by money, influence, and shared secrets that ensure silence among peers. Accountability is treated not as a moral obligation, but as an existential threat to the entire class. Even when a figure is publicly sacrificed, it's almost always to shield the rest of the group and close the wound before more light can get in. The public sees a fall from grace; insiders see a calculated move to protect the structure itself. This is why corruption at the top is rarely punished proportionally—because the system isn't designed to police power, it's designed to preserve it.(commercial at 20:54)To contact me:bobbycapucci@protonmail.comSource:https://www.fairobserver.com/region/north_america/peter-isackson-alex-acosta-federal-prosecutor-jeffrey-epstein-case-us-american-world-news-79671/

In this podcast episode, Dr. John Holcomb discusses the management of traumatic brain injury (TBI) and the innovative use of plasma as a treatment option. He emphasizes the importance of understanding the glycocalyx and its role in preventing edema and managing intracranial pressure (ICP). The conversation also highlights the limitations of current guidelines in TBI treatment and the need for practical considerations in administering plasma. Dr. Holcomb advocates for a shift in practice towards using plasma early in the treatment process to improve patient outcomes.TakeawaysPlasma is used as a drug to prevent edema in TBI patients.The glycocalyx plays a crucial role in brain injury management.Preventing increased ICP is more effective than treating it.Current guidelines often lag behind clinical practice.Understanding the physiology behind treatments is essential for medics.Monitoring blood pressure is critical in TBI management.Plasma can repair the blood-brain barrier and reduce edema.Practical considerations are necessary for administering plasma in the field.The outcomes of TBI treatment should focus on functional recovery.Future directions in TBI management include more research on plasma use.Chapters00:00 Introduction to TBI Management and Plasma Use03:04 Understanding Plasma as a Drug for TBI05:39 The Role of Glycocalyx in Brain Injury08:47 Preventing Edema and Managing ICP11:31 Guidelines and Their Limitations in TBI Treatment14:33 Practical Considerations for Administering Plasma17:29 The Importance of Patient Monitoring and Judgment20:44 Outcomes and Future Directions in TBI ManagementFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠

In June 2022, Maxwell's legal team submitted a 77-page sentencing memorandum to the U.S. District Court in Manhattan requesting a significant downward variance from both the Probation Department's recommendation and the federal Sentencing Guidelines. While the probation office had proposed a 20-year sentence (240 months), Maxwell's attorneys argued she should receive only 51 to 63 months in prison. They maintained that Maxwell should not be punished as a proxy for Jeffrey Epstein, emphasizing he was the principal orchestrator of the crimes and that Maxwell had never before been charged with wrongdoing until her association with him resurfaced. Her defense also cited her difficult and traumatic childhood, abusive father, and the death threats she continues to face as aggravating circumstances warranting leniency.Prosecutors forcefully opposed the request, urging the court instead to impose a prison term within the Guidelines range—between 30 to 55 years—based on Maxwell's “pivotal role” in grooming and recruiting vulnerable young girls for Epstein. They highlighted her lack of remorse, failure to accept responsibility, and the profound and enduring harm caused to numerous victims. The prosecutors made clear that Maxwell's privileged background offered no mitigation given the extreme gravity of her crimes.to contact me:bobbycapucci@protonmail.comsource:https://www.theguardian.com/us-news/2022/jun/15/ghislaine-maxwell-sex-trafficking-sentenceBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

In this episode, Chris William shares the simple guidelines he follows when choosing pre-made meals. From protein targets to calorie caps, Chris explains how to make quick, convenient meals work for your goals without sacrificing progress. If you rely on grab-and-go options but still want to stay on track, this episode is packed with practical tips.

New usage guidelines are live and focus on platform health. They address growing demands in AI workloads. We'll show you how to navigate this update successfully.Try AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Channel: https://www.youtube.com/@JaedenSchaferJoin my AI Hustle Community: https://www.skool.com/aihustle/about

Pain during a cesarean section isn't a new problem. But for a long time, it's been a hidden one. In England, a patient named Susanna not only brings the problem to doctors' attention, but also tries to solve it. Our newest podcast, “The Retrievals, Season 2” is out now. Search for it wherever you get your podcasts, or follow it here: lnk.to/retrievals2 To get full access to this and other Serial Productions and New York Times podcasts on Apple Podcasts and Spotify, subscribe at nytimes.com/podcasts.To find out about new shows from Serial Productions, and get a look behind the scenes, sign up for our newsletter at nytimes.com/serialnewsletter.Have a story pitch, a tip, or feedback on our shows? Email us at serialshows@nytimes.com

In this episode of the International Enneagram Association podcast, we listen to the Endnote presentation by Chichi Agorom from the IEA Global Conference in 2023. Chichi is a certified Enneagram teacher and practitioner, Associate Faculty with the Narrative Enneagram, and holds a Master of Arts in Clinical Mental Health Counseling and a Post-Master's Certificate in Marriage and Family Therapy. Drawing from the theme of the conference–Unite and Ignite–she discusses how the Enneagram can be used as a tool for our collective liberation, drawing from her book, “The Enneagram for Black Liberation.” She explores how motivation behind our behavior and context–social, race, gender, social economics, religion, etc, that impact how we see ourselves and other people–are important for our inner work.Connect with us:Web: internationalenneagram.orgIEA Enneagram Experience 2025: ieaexperience.comJoin the email list: administration@internationalenneagram.orgIEA Conference Proposal Submission Information & Guidelines: internationalenneagram.org/wp-content/uploads/2024/07/2025-Proposal-Submission-Information-Guidelines.pdfIEA Global Podcast Proposal Submission Form: forms.gle/Q48QXSwQ3zDfDJaJAChichi Agorom:Web: chichiagorom.comBook: The Enneagram for Black LiberationIG: @theenneagramforblackliberationAephoria Partners:Web: aephoriapartners.comFB: Aephoria Partners Consulting

** Pre-order my new book: https://geni.us/AtlasOfUFOs ** In this episode, returning guest Karen Alexander, a Crop Circle researcher of over 30 years joins me to look at this years new Circles & get into a bit of the history of the subject: Karen Alexander's Background in Crop Circles What Are Crop Circles Really? Scientific Investigations & Surprising Findings Are Crop Circles a Message or a Mystery? Guidelines for Visiting Crop Circles Can AI Decode Crop Circle Patterns? Doug & Dave: Debunkers or Distraction? Crop Circles, Geometry & Human Consciousness The Truth Behind the Crabwood Alien Circle Are Crop Circles Vanishing — and Why? Links in show: TemporaryTemples.co.uk https://temporarytemples.co.uk/wp-content/uploads/2016/11/Guide-To-Visiting-Crop-Circles.pdf https://www.cropcirclecenter.com/ https://www.ukcropcircles.co.uk/

In today's VETgirl online veterinary continuing education podcast, we interview Jennifer Sager, RVT, CVT, LVT, VTS (Anesthesia & Analgesia) (ECC), Regional Nursing Director, with VEG ER for Pets, and the only veterinary technician contributing author on The American College of Veterinary Anesthesia and Analgesia Small Animal Anesthesia and Sedation Monitoring Guidelines 2025. Tune in to hear what and how you should be monitoring your sedated and anesthetized patients!

In this episode, we dive into the less obvious signs of under-recovery, and why your nervous system, not just your habits, might be the missing piece. But first, we chat about what 5 key aspects to focus on if you're knee-deep in a fall marathon prep. Then, we break down what recovery actually means, how cortisol and hormone shifts affect your sleep and progress, and why fueling and stress perception play a bigger role than you think.Whether you're an endurance athlete, a lifter, or just someone trying to train with intention, this episode will help you rethink how you approach rest, training adaptation, and energy. Because more effort isn't always the answer, smarter recovery is.We'll also give you a clear checklist to spot recovery gaps and practical strategies you can start using today.www.trainmk.com@melissa_kendterMcEwen, B. S., & Stellar, E. (1993). Stress and the individual. Mechanisms leading to disease. Arch Intern Med, 153(18), 2093-2101.Mountjoy, M. et al. (2018). IOC consensus statement: Relative Energy Deficiency in Sport (RED-S). Br J Sports Med, 52(11), 687–697.Harvard Health Publishing (2020). How stress affects the brain and body.American College of Sports Medicine. (2021). ACSM's Guidelines for Exercise Testing and Prescription (11th ed.).Stanford Medicine HRV Research Lab: HRV as a marker of training recovery.

Doctors Lisa and Sara are joined by Medical Microbiology and Infectious Diseases Consultant Dr Callum Mutch for an overview of Antibiotics and Microbiology in General Practice. Doctors Callum and Jame host a podcast in Infectious Diseases called ID:IOTS and we wanted to do a crossover episode exploring common themes in Microbiology that we encounter in General Practice. We talk about the case of a woman with recurrent UTIs and a man with epididymo-orchitis. This lends itself to a discussion on general approaches to cases, microbes and antibiotics. We cover a little bit about antimicrobial stewardship at the end.    You can use these podcasts as part of your CPD - we don't do certificates but they still count :) Resources: Podcast: Infectious Diseases Insight of Two Specialists (ID:IOTS): https://www.britishinfection.org/education-events/idiots-podcast Antimicrobial Counselling Resources from Public Health Wales: https://phw.nhs.wales/services-and-teams/antibiotics-and-infections/harp-news/eaadwaaw-2021/resources/community-pharmacy-counselling-checklist/ Antimicrobial Counselling RCGP TARGET Resources: https://elearning.rcgp.org.uk/mod/book/view.php?id=12647 The Cynefin Framework for looking at decisions (Simple, complicated, Complex, Chaos): https://thecynefin.co/about-us/about-cynefin-framework/?srsltid=AfmBOopHNprchcOsISLVvXm2C5W-UU-oqHDkty_jo1IAAsupfoMu4_Cx Shared Decision Making Tool BRAN - Benefits, Risks, Alternatives, Nothing: https://www.england.nhs.uk/personalisedcare/shared-decision-making/decision-support-tools/how-to-use-a-decision-support-tool/#:~:text=Prepare%20patients%20to%20share%20decisions&text=In%20addition%20to%20the%20proactive,Nothing)%20or%20equivalent%20local%20initiatives World Health Organisation AWaRe Book: Access, Watch, Reserve Antimicrobial Book (can aid in decision making around which antibiotics to use. Accessed May 2025):  https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2022.02 UK Health Security Agency Adaptation of the Access, Watch, Reserve (AWaRe) Guidelines: https://www.gov.uk/government/publications/uk-aware-antibiotic-classification/uk-access-watch-reserve-and-other-classification-for-antibiotics-uk-aware-antibiotic-classification ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback Email us at: primarycarepodcasts@gmail.com ___ This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

Tiago Arnaud convida Djoni Moraes, Internista pelo HCFMUSP, para discutir um caso clínico de vômitos recorrentes e diarreia apresentado pela Ana Carolina Malvaccini.Referencias:1. https://www.tadeclinicagem.com.br/guia/381/abordagem-a-diarreia-cronica/2. Tome J, Kamboj AK, Sweetser S. A Practical 5-Step Approach to Nausea and Vomiting. Mayo Clin Proc. 2022;97(3):600-608. doi:10.1016/j.mayocp.2021.10.0303. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018;67(8):1380-1399. doi:10.1136/gutjnl-2017-3159094. Schiller LR, Pardi DS, Sellin JH. Chronic Diarrhea: Diagnosis and Management. Clin Gastroenterol Hepatol. 2017;15(2):182-193.e3. doi:10.1016/j.cgh.2016.07.0285. BONIS, Peter AL; LAMONT, J. Thomas. Approach to the adult with chronic diarrhea in resource-abundant settings. 2022.

Nutrition science plays a pivotal role in shaping public health advice, but the influence of industry funding on research has become a pressing concern. In this episode we want to examine whether we can trust nutrition studies funded by food and beverage companies, and how you can discern study credibility.  The discussion is highly relevant in today's landscape, where conflicts of interest and bias in research are under scrutiny amidst debates on sugar, processed foods, and diet recommendations. By exploring how industry sponsorship might skew results or interpretations, this episode speaks to broader issues of scientific trustworthiness and evidence-based policy in nutrition and public health.  In this episode, we take a look at some recent publications that showed how study results and reporting differed significantly depending on if industry had funded the study or not. We delve into how this happens. As most often it is not a case of data fabrication or corruption, but rather how bias leads to studies being designed and reported differently. We walk through some examples, as well as highlighting some industry-funded studies that didn't provide a “pro-industry” result and conclusion. The hope is that the episode allows you to understand why this is a problem, how to spot it, and how to know if you can trust the results of an industry-funded study. Timestamps [00:36] Alan's upcoming study [04:47] Discussion on industry funding in nutrition research [15:06] Case study: industry influence on red meat research [30:43] Case study: artificial sweeteners and industry influence [36:37] Case study: sugar industry's role in research [38:06] Critical appraisal of industry-funded studies [51:58] Case study: when industry-funded study results can be trusted [01:01:51] Guidelines for assessing research quality [01:07:14] Key ideas segment (premium-only) Related Resources Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Join Alan's Alinea Nutrition Research Hub Enroll in the next cohort of our Applied Nutrition Literacy course Recommended episode: #472: Compared To What? – Understanding Food Substitution Analysis & Adjustment Models Studies mentioned: López-Moreno et al., Am J Clin Nutr. 2025 Jun;121(6):1246-1257 Tobias, 2025 – You are what you don't eat Mandrioli D, Kearns CE, Bero LA (2016) PLOS ONE 15(3): e0230469 Schillinger et al., Ann Intern Med. 2016 Nov 1;165(12):895–897 Schmidt et al., 2021 – The impact of diets rich in low-fat or full-fat dairy on glucose tolerance and its determinants: a randomized controlled trial Schmidt et al., 2021 – Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial

The FY 2026 ICD-10-CM Official Guidelines are out. In this episode, Terry breaks down the key updates and what they mean for your coding workflow. Tune in as she covers: New considerations for diagnosis coding in heart disease, HIV, and diabetes How to apply the latest guidance across multiple specialties A closer look at inpatient […] The post ICD-10-CM Official Guidelines for FY 2026 appeared first on Terry Fletcher Consulting, Inc..

Heart failure remains one of the most urgent challenges in health care, affecting millions of individuals and imposing a significant burden on families and the broader health system. Although guideline-directed medical therapy (GDMT) has been shown to improve clinical outcomes and reduce hospitalizations, adoption of these therapies remains suboptimal nationwide. Addressing this treatment gap is essential not only for enhancing survival and quality of life but also for mitigating the rising economic impact of heart failure as its prevalence continues to increase. Gluckman also led the session “Addressing Underuse of Guideline-Directed Medical Therapy in Heart Failure” at the July 9 Institute for Value-Based Medicine® (IVBM) event in Garden Grove, CA, where he addressed the need for integrated approaches to drive sustainable, system-level change in cardiovascular care. On this episode of Managed Care Cast, Ty Gluckman, MD, MHA, FACC, FAHA, FASPC—a practicing cardiologist at Providence Heart Institute in Portland, Oregon, and medical director of Providence's Center for Cardiovascular Analytics, Research, and Data Science—discusses strategies to improve GDMT implementation. The conversation explores opportunities for payers and providers, the potential of remote patient monitoring and digital health tools, and the role of value-based care models in supporting optimal therapy. Emphasis is placed on the importance of aligning clinical guidelines with managed care policies to drive meaningful improvements in patient outcomes.

Summary In this truncated replay from a session at the 2025 SF Derm Annual Conference, Dr. Daniel Butler, Dr. Lawrence Eichenfield, Dr. Jason Hawkes, Dr. Shyam Joshi, and Dr. Bob Geng discuss the workup for chronic urticaria, focusing on testing approaches, the role of biomarkers, and insights into immune deficiencies. These panelists share their experiences and guidelines, emphasizing the importance of symptomatic management and the variability of lab results in clinical practice. Takeaways - Initial workup for chronic urticaria often does not require specific testing. - Testing may be justified if standard treatments fail. - International guidelines differ from US guidelines regarding testing. - Biomarkers currently available are not reliable for treatment decisions. - Symptomatic management should be prioritized over extensive testing. - Clinical trials show variability in lab results over time. - Excessive lab testing can lead to confusion and unnecessary anxiety for patients. - Understanding patient history is crucial in diagnosing immune deficiencies. - The role of family history is significant in identifying X-linked conditions. - Collaboration among dermatologists is essential for advancing treatment approaches. Chapters 00:00 - Introduction to Chronic Urticaria Workup 02:47 - Testing Approaches and Guidelines for Chronic Urticaria 05:41 - The Role of Biomarkers in Treatment Decisions 08:16 - Clinical Insights on Immune Deficiencies 11:14 - Variability in Lab Results and Clinical Trials 14:07 - Conclusion and Future Directions in Dermatology

Welcome to the Plant-Based Canada Podcast! In today's episode, we're joined by (soon to be Dr.) Amy Symington.Amy Symington is a Toronto-based nutrition professor, researcher, and plant-focused chef with over 25 years in the food industry and more than 12 years of teaching experience. She holds a Master of Science in Applied Human Nutrition and is currently pursuing a PhD in Nutritional Sciences at the University of Toronto. Amy leads culinary nutrition programming at Gilda's Toronto, a not-for profit cancer support organization, and works with Humane World for Animals Canada's Forward Food team, training executive chefs in hospitals and universities on plant-forward menu planning aligned with Canada's Food Guide. She also supports the Toronto Vegetarian Food Bank as a chef, consultant, and instructor. An award-winning author, Amy wrote The Long Table Cookbook: Plant-based Recipes for Optimal Health and regularly contributes recipes and nutrition writing to national and international publications. A passionate advocate for evidence-based, sustainable eating, she is also the proud mother of two healthy vegan children. As part of her PhD she is currently working on a clinical trial investigating omega-3 polyunsaturated fatty acid docosahexaenoic acid (also known as DHA). DHA is considered an important omega-3 fatty acid that research has shown to help support brain, eye, and heart health, reduce inflammation, and be important for fetal and infant development.Amy Symington's Socials:Website: https://ameliaeats.com/home Researchgate: https://www.researchgate.net/profile/Amy-Symington-3Instagram: https://www.instagram.com/ameliaeats/?hl=enPlant-Based Canada's Socials:Instagram  (@plantbasedcanadaorg)Facebook (Plant-Based Canada, https://m.facebook.com/plantbasedcanadaorg/)Website  (https://www.plantbasedcanada.org/)X / Twitter @PBC_orgBonus PromotionCheck out University of Guelph's online Plant-Based Nutrition Certificate. Each 4-week course will guide you through essential plant-based topics including nutritional benefits, disease prevention, and environmental impacts. You can also customize your learning with unique courses such as Plant-Based Diets for Athletes and Implementing a Plant-Based Diet at Home. As the first university-level plant-based certificate in Canada, you'll explore current research, learn from leading industry experts, and join a community of like-minded people. Use our exclusive discount code PBC2025 to save 10% on all Plant-Based Nutrition Certificate courses. uoguel.ph/pbn.Thank you for tuning in! Make sure to subscribe to the Plant-Based Canada Podcast so you get notified when new episodes are published. This episode was hosted by Stephanie Nishi RD, PhD.Support the show

Episode Summary: AWS Morning Brief for the week of August 4th, 2025, with Corey Quinn. Amazon Aurora MySQL database clusters now support up to 256 TiB of storage volume Introducing v2 of Powertools for AWS Lambda (Java)Introducing Extended Support for Amazon ElastiCache version 4 and version 5 for Redis OSSAmazon DocumentDB Serverless is now available AWS Lambda response streaming now supports 200 MB response payloadsHow Zapier runs isolated tasks on AWS Lambda and upgrades functions at scaleAmazon Application Recovery Controller now supports Region switchAnnouncing general availability of Amazon EC2 G6f instances with fractional GPUsAmazon Promotes Malphas to Senior Vice President of Bad Decisions, Unveils 17th Leadership PrincipleAmazon CloudFront introduces new origin response timeout controlsOptimize traffic costs of Amazon MSK consumers on Amazon EKS with rack awarenessAmazon Bedrock now available in the US West (N. California) RegionNew AWS whitepaper: AWS User Guide to Financial Services Regulations and Guidelines in Australia Amazon EC2 Auto Scaling adds AWS Lambda functions as notification targets for lifecycle hooks

In today's episode, we had the pleasure of speaking with Martin F. Dietrich, MD, PhD, about updates and best practices for HER2 and MET immunohistochemistry (IHC) testing for patients with non–small cell lung cancer (NSCLC). Dr Dietrich is a medical oncologist at Cancer Care Centers of Brevard in Rockledge, Florida; as well as an assistant professor of internal medicine at the University of Central Florida in Orlando.  In our exclusive interview, Dr Dietrich discussed the rationale for testing for these mutations in patients with NSCLC, standard practices for implementing these tests in the clinic, and when testing may be appropriate at disease progression. 

The NM PED has released A.I. Guidelines for schools plus Deigo Sanchez wild day getting arrested recently on News Radio KKOBSee omnystudio.com/listener for privacy information.

Listener discretion is advised. References: Cook AM, Morgan Jones G, Hawryluk GWJ, Mailloux P, McLaughlin D, Papangelou A, Samuel S, Tokumaru S, Venkatasubramanian C, Zacko C, Zimmermann LL, Hirsch K, Shutter L. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020 Jun;32(3):647-666. doi: 10.1007/s12028-020-00959-7. PMID: 32227294; PMCID: PMC7272487. Desai A, Damani R. Hyperosmolar therapy: A century of treating cerebral edema. Clin Neurol Neurosurg. 2021 Jul;206:106704. doi: 10.1016/j.clineuro.2021.106704. Epub 2021 May 20. PMID: 34045110. Mount CA, Das JM. Cerebral Perfusion Pressure. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537271/ Susanto M, Riantri I. Optimal Dose and Concentration of Hypertonic Saline in Traumatic Brain Injury: A Systematic Review. Medeni Med J. 2022 Jun 23;37(2):203-211. doi: 10.4274/MMJ.galenos.2022.75725. PMID: 35735001; PMCID: PMC9234368.

Big changes are brewing. U.S. health officials are expected to overhaul long-standing alcohol guidelines and the new science (and common sense person) says even one drink a day might be too much. In this episode, we unpack what these changes mean for you, the $250B alcohol industry, and why it's time to ditch the “moderate drinking is healthy” myth once and for all.We dig into the latest research, what's really happening behind closed doors in Washington (and the boardrooms of Big Alcohol), and how this shift impacts men, fathers, leaders, and anyone trying to level up without the drag of booze.You'll also get a few solid takeaways to help you think clearly, lead better, and start showing up as your best self—without the crutch of “just one drink.”

In this episode of the PFC Podcast, Dennis and John discuss the complexities of chest trauma management, focusing on the use of chest seals, the importance of patient assessment, and the evolving guidelines in tactical medicine. They explore the debate surrounding the March algorithm, the role of blood transfusions, and the techniques for needle decompression and finger thoracotomy. The conversation emphasizes the need for a systematic approach to trauma care and the importance of adapting medical practices based on real-world experiences and outcomes.TakeawaysChest seals can be overused and may cause harm.Patient assessment is crucial before applying interventions.The March algorithm may need reevaluation based on new data.Blood transfusion should be prioritized in trauma care.Needle decompression and finger thoracotomy have distinct roles.Effective thoracotomy techniques can improve patient outcomes.Managing hemothorax and pneumothorax requires careful consideration.Guidelines for chest trauma are evolving based on practical experiences.Training should reflect realistic scenarios in trauma care.Continuous assessment is key in trauma management.Chapters00:00 Introduction to Chest Trauma Management02:56 Understanding Chest Seals and Their Use05:53 The Debate on Chest Seal Application08:31 The Importance of Patient Assessment11:37 Revisiting the March Algorithm14:33 The Role of Blood Transfusion in Trauma17:15 Needle Decompression vs. Finger Thoracotomy20:09 Techniques for Effective Thoracotomy23:16 Managing Hemothorax and Pneumothorax26:01 The Future of Chest Trauma GuidelinesThank you to Delta Development Team for in part, sponsoring this podcast.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

This episode covers:  Cardiology this Week: A concise summary of recent studies Atrial fibrillation in heart failure Temperature management following cardiac arrest Statistics Made Easy: Collider bias Host: Emer Joyce Guests: Carlos Aguiar, Christian Hassager, Theresa McDonagh Want to watch that episode? Go to: https://esc365.escardio.org/event/1812 Want to watch that extended interview on temperature management following cardiac arrest? Go to: https://esc365.escardio.org/event/1812?resource=interview   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails.   Declarations of interests Stephan Achenbach, Emer Joyce, Christian Hassager, Nicolle Kraenkel and Theresa McDonagh have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Emer Joyce Guest: Christian Hassager Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1812?resource=interview  Want to watch the full episode? Go to: https://esc365.escardio.org/event/1812   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails.   Declarations of interests Stephan Achenbach, Emer Joyce, Christian Hassager, Nicolle Kraenkel and Theresa McDonagh have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.  

IBD Drive Time: David Rubin, MD, on ACG Guidelines for Ulcerative Colitis by Gastroenterology Learning Network

In June 2022, Maxwell's legal team submitted a 77-page sentencing memorandum to the U.S. District Court in Manhattan requesting a significant downward variance from both the Probation Department's recommendation and the federal Sentencing Guidelines. While the probation office had proposed a 20-year sentence (240 months), Maxwell's attorneys argued she should receive only 51 to 63 months in prison. They maintained that Maxwell should not be punished as a proxy for Jeffrey Epstein, emphasizing he was the principal orchestrator of the crimes and that Maxwell had never before been charged with wrongdoing until her association with him resurfaced. Her defense also cited her difficult and traumatic childhood, abusive father, and the death threats she continues to face as aggravating circumstances warranting leniency.Prosecutors forcefully opposed the request, urging the court instead to impose a prison term within the Guidelines range—between 30 to 55 years—based on Maxwell's “pivotal role” in grooming and recruiting vulnerable young girls for Epstein. They highlighted her lack of remorse, failure to accept responsibility, and the profound and enduring harm caused to numerous victims. The prosecutors made clear that Maxwell's privileged background offered no mitigation given the extreme gravity of her crimes.to contact me:bobbycapucci@protonmail.comsource:https://www.theguardian.com/us-news/2022/jun/15/ghislaine-maxwell-sex-trafficking-sentence

In today's episode, Jessie and Anita talk all about cardiovascular training in pregnancy. Is it safe for pregnant women to do cardiovascular exercise or interval training in pregnancy? We will break it down in an evidence-based fashion - what CAN you do? What's safe? What does the evidence say? Tune in to today's episode to find out!- - - - - - - - -If you liked this episode of To Birth and Beyond, tell your friends! Find us on iTunes and Spotify to rate/review/subscribe to the show.Want more? Visit www.ToBirthAndBeyond.com, join our Facebook group (To Birth and Beyond Podcast), and follow us on Instagram @tobirthandbeyondpodcast! Thanks for listening and joining the conversation!Resources and References Join Jessie's free, LIVE, Build Beta TestShow Notes 0:55 - Join Jessie's Build Beta Test!2:28 - Jessie and Anita introduce today's episode3:19 - What we know for sure…5:15 - The benefits of cardiovascular exercise in pregnancy8:04 - What kind of exercise “counts” as cardio?10:49 - Let's talk about heart rate!15:21 - If you are coming back to cardiovascular activity in pregnancy after a break, or starting from scratch…18:25 - Key safety points when talking about cardiovascular and interval training work in pregnancy22:22 - Episode wrap up

Not all toys are created equal!! Make sure you know which ones are WORTH your time and which ones you might need to DITCH!Do you want the details on how to choose the right toys for your baby AND at each stage??To find out what to look for, this episode has ALL you need!I sat down with Rachel and Jessica, founders of the All Things Sensory Podcast! We did a deep dive into the best kinds of sensory toys, developmental milestones to keep an eye out for, and SO MUCH MORE!This episode spills on:- Educational toys for infants 0-12 months- How do toys affect child development?- Baby container usage- What is the average age a baby starts walking?- What are the best developmental toys for babies?- Baby toys that are bad for development- DIY sensory baby toys- Guidelines for choosing developmentally appropriate toys- How to help baby developmentAnd more!----------------------------------------------------------------------------IMPORTANT LINKS:•Crunchi Makeup and Skincare HERE          ◦ Use Code ADVOCATE10 for 10% off!•Shop Laila's Clean Makeup Bag Staples HERE•Truly Free Home- Toxin Free Laundry Detergent and Cleaning Supplies HERE          ◦ Use Code LEARNINGTOMOM for 30% off!Connect with Rachel and Jessica HERE----------------------------------------------------------------------------Montessori baby toys diy, sensory baby toys diy, baby toys developmental stages, baby toys infant, baby toys less than 6 months, baby toys developmental, baby toys learning, baby toys newborn to 6 months, baby toys non-toxic, baby toys natural, baby toys high quality, baby toys sensory, baby toys toddler, baby toys under 1 year, baby toys year old, baby toys under 3 months, baby toys 3-6 months, baby toys 0-3, baby toys 0-6, baby toys 4-6 months, baby toys 10 months, baby toys 12 months, baby toys 7-12 months, baby toys 8-12 months, baby toys 5 months montessori, baby toys, baby toys to encourage rolling, baby toys to encourage standing, baby toys to help sit up, baby toys for development, baby toys for 2-month old, baby toys for 9-month old, baby toys for 4-month old, baby toys for 1-year old, baby toys for 6 month old, baby toys for 3 month old, baby toys to encourage crawling, baby toys to help crawl, baby toys to help stand, baby toys to help walk, what toys should a pediatrician recommend, what toys should you buy a newborn, what should be baby's first toy, what are the first toys for babies, should a 4 month-old be reaching for toys, what should a 4-month old be playing with, what toys should a 4 month-old have, what toys can a 4 month-old have, when should you start plkaying with toys with your baby, does a 2-month old need toys, should a 2-month old have toys, what are baby sensory toys, what are the best baby toys, what are baby toys used for, what are good baby toys, what baby toys do I really need, what are montessori baby toys, how do baby toys help development, what toys should 1 year old have, what are good learning toys for 1 year old, educational toys for one year old baby, Mom podcast, parenting podcast, First time mom podcast,  motherhood podcast, postpartum podcast, infant podcast, newborn care podcast, new baby podcast, pregnancy podcast, how to parent, parenting tips, parenting advice, 2 month old, 3 month old, 4 month old, 5 month old, 6 month old, 7 month old, 8 month old, 9 month old, 10 month old, 11 month old, 12 month old

This week's show covers managed bond accounts, sources of returns, what to do with inherited accounts, and lots of emails!

July 27, 2025 - Sunday AM Sermon   FROM "CLACK" TO "CLICK"  Neal Pollard    Introduction    A. God's Guidelines for Navigating Marriage Turbulence:     1. Marriage is ________________________     2. Marriage doesn't have to be _________ into, but if we do, we must follow God's                               ____________                                          3. Marriage is for ____________ and ___________ God-given ___________     4. Marriage is ___________ participated in by two ____________    B. How Can We Pull Out Of ____________?    I. _______________________     A. What Are Issues That __________ Good _______________?        B. Healthy _____________ Starts With ____________, _____________, And           ______________     C. Make Sure You Devote Sufficient ____________ to ______________    II. ___________________    III. __________________    IV. __________________    V. _____________ WITH ________________    Conclusion    A. Are You "____________" Each Other Or Constantly ____________? You Decide!   Duration 40:36

With the increase in the public's attention to all aspects of brain health, neurologists need to understand their role in raising awareness, advocating for preventive strategies, and promoting brain health for all. To achieve brain health equity, neurologists must integrate culturally sensitive care approaches, develop adapted assessment tools, improve professional and public educational materials, and continually innovate interventions to meet the diverse needs of our communities. In this BONUS episode, Casey Albin, MD, speaks with Daniel José Correa, MD, MSc, FAAN and Rana R. Said, MD, FAAN, coauthors of the article “Bridging the Gap Between Brain Health Guidelines and Real-world Implementation” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Correa is the associate dean for community engagement and outreach and an associate professor of neurology at the Albert Einstein College of Medicine Division of Clinical Neurophysiology in the Saul Korey Department of Neurology at the Montefiore Medical Center, New York, New York. Dr. Said is a professor of pediatrics and neurology, the director of education, and an associate clinical chief in the division of pediatric neurology at the University of Texas Southwest Medical Center in Dallas, Texas. Additional Resources Read the article: Bridging the Gap Between Brain Health Guidelines and Real-world Implementation Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Guests: @NeuroDrCorrea, @RanaSaidMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. This exclusive Continuum Audio interview is available only to you, our subscribers. We hope you enjoy it. Thank you for listening. Dr Albin: Hi all, this is Dr Casey Albin. Today I'm interviewing Dr Daniel Correa and Dr Rana Said about their article on bridging the gap between brain health guidelines and real-world implementation, which they wrote with Dr Justin Jordan. This article appears in the June 2025 Continuum issue on disorders of CSF dynamics. Thank you both so much for joining us. I'd love to just start by having you guys introduce yourselves to our listeners. Rana, do you mind going first? Dr Said: Yeah, sure. Thanks, Casey. So, my name is Rana Said. I'm a professor of pediatrics and neurology at the University of Texas Southwestern Medical Center in Dallas. Most of my practice is pediatric epilepsy. I'm also the associate clinical chief and the director of education for our division. And in my newer role, I am the vice chair of the Brain Health Committee for the American Academy of Neurology. Dr Albin: Absolutely. So just the right person to talk about this. And Daniel, some of our listeners may know you already from the Brain and Life podcast, but please introduce yourself again. Dr Correa: Thank you so much, Casey for including us and then highlighting this article. So yes, as you said, I'm the editor and the cohost for the Brain and Life podcast. I do also work with Rana and all the great members of the Brain Health Initiative and committee within the AAN, but in my day-to-day at my institution, I'm an associate professor of neurology at the Albert Einstein College of Medicine in the Montefiore Health System. I do a mix of general neurology and epilepsy and with a portion of my time, I also work as an associate Dean at the Albert Einstein College of Medicine, supporting students and trainees with community engagement and outreach activities. Dr Albin: Excellent. Thank you guys both so much for taking the time to be here. You know, brain health has really become this core mission of the AAN. Many listeners probably know that it's actually even part of the AAN's mission statement, which is to enhance member career fulfillment and promote brain health for all. And I think a lot of us have this kind of, like, vague idea about what brain health is, but I'd love to just start by having a shared mental model. So, Rana, can you tell us what do you mean when you talk about brain health? Dr Said: Yeah, thanks for asking that question. And, you know, even as a group, we really took quite a while to solidify, like, what does that even mean? Really, the concept is that we're shifting from a disease-focused model, which we see whatever disorder comes in our doors, to a preventative approach, recognizing that there's a tremendous interconnectedness between our physical health, our mental health, cognitive and social health, you know, maintaining our optimal brain function. And another very important part of this is that it's across the entire lifespan. So hopefully that sort of solidifies how we are thinking about brain health. Dr Albin: Right. Daniel, anything else to add to that? Dr Correa: One thing I've really liked about this, you know, the evolution of the 2023 definition from the AAN is its highlight on it being a continuous state. We're not only just talking about prevention of injury and a neurologic condition, but then really optimizing our own health and our ability to engage in our communities afterwards, and that there's always an opportunity for improvement of our brain health. Dr Albin: I love that. And I really felt like in this article, you walked us through some tangible pillars that support the development and maintenance of this lifelong process of maintaining and developing brain health. And so, Daniel, I was wondering, you know, we could take probably the entire time just to talk about the five pillars that support brain health. But can you give us a pretty brief overview of what those are that you outlined in this article? Dr Correa: I mean, this was one of the biggest challenges and really bundling all the possibilities and the evidence that's out there and just getting a sense of practical movement forward. So, there are many organizations and groups out there that have formed pillars, whether we're calling them seven or eight, you know, the exact number can vary, but just to have something to stand on and move forward. We've bundled one of them as physical and sleep health. So really encouraging towards levels of activity and not taking it as, oh, that there's a set- you know, there are recommendations out there for amount of activity, but really looking at, can we challenge people to just start growing and moving forward at their current ability? Can we challenge people to look at their sleep health, see if there's an aspect to improve, and then reassess with time? We particularly highlight the importance of mental health, whether it's before a neurologic condition or a brain injury occurs or addressing the mental health comorbidities that may come along with neurologic conditions. Then there's of course the thing that everyone thinks about, I think, with brain health in terms of is cognitive health. And you know, I think that's the first place that really enters either our own minds or as we are observers of our elder individuals in our family. And more and more there has been the highlight on the need for social interconnectedness, community purpose. And this is what we include as a pillar of social health. And then across all types of neurologic potential injuries is really focusing on the area of brain injury. And so, I think the area that we've often been focused as neurologists, but also thinking of both the prevention along with the management of the condition or the injury after it occurs. Dr Albin: Rana, anything else to add to that? That's a fantastic overview. Dr Said: Daniel, thank you for- I mean, you just set it up so beautifully. I think the other thing that maybe would be important for people to understand is that as we're talking through a lot of these, these are individual. These sound like very individual-basis factors. But as part of the full conversation, we also have to understand that there are some factors that are not based on the individual, and then that leads to some of the other initiatives that we'll be talking about at the community and policy levels. So, for example, if an individual is living in an area with high air pollution. Yes, we want them to be healthy and exercise and sleep, but how do we modify those factors? What about lead leaching from our aging pipes or even infectious diseases? So, I think that outside of our pillars, this is sort of the next step is to understand what is also at large in our communities. Dr Albin: That's a really awesome point. I love that the article really does shine through and that there are these individual factors, and then there there's social factors, there's policy factors. I want to start just with that individual because I think so many of our patients probably know, like, stress management, exercise, sleep, all of that stuff is really important. But when I was reading your article, what was not so obvious to me was, what's the role that we as neurologists should play in advocating? And really more importantly, like, how should we do that? And again, it struck me that there are these kind of two issues at play. And one is that what Daniel was saying that, you know, a lot of our patients are coming because they have a problem, right? We are used to operating in this disease-based care, and there's just limited time, competing clinical demands. If they're not coming to talk about prevention, how do we bring that in? And so Rana, maybe I'll start with you just for that question, you know, for the patients who are seeing us with a disease complaint or they're coming for the management of a problem, how are you organizing this at the bedside to kind of factor in a little bit about that preventative brain health? Dr Said: You know, I think the most important thing at the bedside is, one, really identifying the modifiable risk factors. These have been well studied, we understand them. Hypertension, diabetes, smoking, weight management. And we know that these definitely are correlative. So is it our role just to talk about stroke, or should we talk about, how are you managing your blood pressure? Health education, if there was one major cornerstone, is elevating health literacy for everyone and understanding that patients value clear and concise information about brain health, about modifiable risk factors. And the corollary to that, of course, are what are the resources and services? I completely understand---I'm a practicing clinician---the constraints that we have at the bedside, be it in the hospital or in our clinics. And so being the source of information, how are we referring our families and individuals to social workers, community health worker support, and really partnering with them, food banks, injury prevention programs, patient advocacy organizations? I think those are really ways that we can meet the impacts that we're looking at the bedside that can feel very tangible and practical. Dr Albin: That's really excellent advice. And so, I'd like to ask a follow-up question. With your knowledge of this, trying to get more multidisciplinary buy-in from your clinic so that you really have the support to get these services that are so critically important. And how do you do that? Dr Said: Yeah, I think it's, one, being a champion. So, what does a champion mean? It means that somebody has to decide this is really important. And I think we all realize that we're not the only ones in the room who care about this. We're all in this, and we all care about it. But how do we champion it and carry it through? And so that's the first. Second you find your partnerships: your social workers, your case managers, your other colleagues. And then what is the first-level entry thing that you can do? So for example, I'm a pediatric epileptologist. One of the things we know is that in pediatric epilepsy, depression and anxiety are very strong comorbidities. So, before we get to the point where a child is in distress, every single one of our epilepsy patients who walks in the door over the age of twelve has an age-appropriate screener that is given to them in both English and Spanish. And we assess it and we determine stratifying risk. And then we have our social workers on the back end and we decide, is this a child who needs resources? Is this a child who needs to be walked to the emergency room, escorted? And anything in between. And I think that that was a just a very tangible example of, every single person can do this and ask about it. And through the development of dot phrases and clear protocols, it works really well. Dr Albin: I love that, the way that you're just being mindful. At every step of the way, we can help people towards this lifelong brain health. And Daniel, you work with an adult population. So I wonder, what are your tips for bringing this to a different patient population? Dr Correa: Well, I think---adult or child---one thing that we often are aware of with so many of the other things that we're doing in bedside or clinic room counseling, but we don't necessarily think of in this context of brain health, is, remember all the people in the room. So, at the bedside, whether it's in the ICU, discharge counseling, the initial admission, the whole family is often involved and really concerned about the active issue. But you can look for opportunities- we often try to counsel and support families about the importance of their own sleep and rest and highlighting it not just as being there for their family member, but highlighting it to them as a measure of their own improvement of their brain health. So, looking at ways where, one, I try to find, is there something I can do to support and educate the whole family about their brain health? And then- and with an epilepsy, or in many other situations, I try to look for one comorbidity that might be a pillar of brain health to address that maybe I wasn't already thinking. And then I consider, is there an additional thing that they wouldn't naturally connect to their epilepsy or their headaches that I can bring in for them to work on? You know, we can't often give people twelve different things to work on, and they'd just feel like, okay like, you have no realistic understanding of my life. But if we can just highlight on one, and remind them that there can be many more ways to improve their health and to follow up either with us as their neurologist or their future primary care doctors to address those additional needs. Again, I would really highlight the importance of a multidisciplinary approach and looking for opportunities. We've too often, I feel, relied on primary care as being the first line for addressing unmet social health needs. We know that so many people, once they have a neurologic condition or the potential, even, of a neurologic condition, they're concerned about dementia or something, they may view us, as their neurologist, as their most important provider. And if they don't have the resource of time and money to show up at other doctors, we may be the first one they're coming to. And so, tapping into your institution's resources and finding out, are there things that are available to the primary care services that for some reason we're not able to get on the inpatient side or the outpatient side? Referring to social workers and care workers and showing that our patients have an independent need, that they're not somehow getting captured by the primary care doctors. Dr Albin: I really love that. I think that we- just being more invested and just being ready to step into that role is really important. I was noticing in this article, you really call that being a brain health ambassador, being really mindful, and I will direct all of our listeners to Figure 3, which really captures what practitioners can do both at the bedside, within their local community, and even at the professional society level, to really advocate for policies that promote brain wellness. Rana, at the very beginning of this conversation, you noted, you know, this is not just an individual problem. This really is something that is a component of our policy and the structure of our local communities. I really loved in the article, there's a humility that this cannot be just a person-by-person bedside approach, that this is a little bit determined by the social determinants of health. And so, Rana, can you walk us through a little bit of what are the social determinants of health, and why are these so crucially important when we think about brain health for all? Dr Said: Yeah, social determinants of health are a really key factor that it looks at, what are the health factors that are environmental; for example, that are not directly like what your blood pressure is, what, you know, what your BMI is, that definitely impact our health outcomes. So, these include environmental things like where people are born, where they live, where they learn, work, play, worship, and age. It encompasses factors like your socioeconomic status, your education, the neighborhoods where you are living, definitely healthcare access. And then all of this is in a social and community context. We know that the impact of social determinants of health on brain health are profound for the entire lifespan and that- so, for example, if someone is from a disadvantaged background or that leads to chronic stress, they can have limited access to healthcare. They can have greater risk of exposure to, let's say, environmental toxins, and all of that will shape how their brain health is. Violence, for example. And so, as we think about how we're going to target and enhance brain health, we really have to understand that these are vulnerable populations, special high-risk populations, that often have a disproportionate burden of neurologic disorders. And by identifying them and then developing targeted interventions, it promotes health equity. And it really has to be done in looking at culturally- ethnocultural-sensitive healthcare education resources, thinking about culturally sensitive or adaptive assessment tools that work for different populations so that these guidelines that we have, that we've already identified as being so valuable, can be equitably applied, which is one crucial component of reducing brain health risk factors. And lastly, at the neighborhood level, this is where we really rely on our partnerships with community partners who really understand their constituents and they understand how to have the special conversations, how to enhance brain health through resource utilization. And so, this is another plug for policy and resources. Dr Albin: I love that. And thinking about the neighborhood and the policy levels and all the things that we have to do. Daniel, I'd like to ask you, is there anything else you would add? Dr Correa: Yeah, you know, so I really wanted to come back to this thing is that often and unfortunately, in the beginning understanding of social determinants of health, they're thought of as a positive or a negative factor, and often really negative. These are just facts. They're aspects about our community, our society, and some of them may be at the individual level. They're not at fault of any individual or community, or even our society. They're just the realities. And when someone has a factor that may predict a health disparity or an unmet social need---I wanted to come back to that concept and that term---one or two positive factors that are social determinants of health for that individual are unmet social needs. It's a point of promise. It's a potential to be addressed. And seeking ways to connect them with community services, social work, caregivers, these are ways where- that we can remove a barrier to, so that the possibility of the recommendations that we're used to doing, giving recommendations about medications and management, can be fully appreciated for that person. And the other aspect is, like brain health, this is a continuous state. The social determinants of health may be different for the child, the parent, and the elderly family member in the household, and there might be some that are shared across them. And when one of those individuals has a new medical illness or a new condition, a stroke, and now has a mobility limitation, that may change a social determinant of health for that person or for anyone else in the family, the other people now becoming caregivers. We're used to this. And for someone after a stroke or traumatic brain injury, now they have mobility changes. And so, we work on addressing those. But thinking on how those things now become a barrier for engaging with community and accessing things, something as simple as their pharmacy. Dr Albin: I hear a lot of “this is a fluid situation,” but there's hope here because these are places that we can intervene and that we can really champion brain health throughout this fluid situation. Which kind of brings me to what we're going to close out with, which is, I'm going to have you do a little thought exercise, which is that you find a magic lamp and a genie comes out. And we'll call this the brain health genie. The genie says that they are going to grant you one wish for the betterment of brain health. Daniel, I'll start with you. What is the one thing that you think could really move the needle on promoting and maintaining brain health? Dr Correa: I will jump on nutrition and food access. If we could somehow get rid of food insecurity and have access to whole and fresh foods for everyone, and people could go back to looking at opportunities from their ancestral and cultural experiences to cook and make whole-food recipes from their own cultures. Using something like the Mediterranean diet and the mind diet as a framework, but not looking at those as cultural barriers that we somehow all have to eat a certain way. So, I think that would really be the place I would go to first that would improve all of our brain health. Dr Albin: I love that. So, wholesome eating. Rana, how about you? One magic wish. Dr Said: I think traumatic brain injury prevention. I think it's so- it feels so within our reach, and it just always is so heart-hurting when you think that wearing helmets, using seatbelts, practicing safety in sports, gun safety---because we know unfortunately that in pediatric patients, firearm injury is the leading cause of traumatic brain injury. In our older patients, fall reduction. If we could figure out how to really disseminate the need for preventative measures, get everyone really on board, I think this is- the genie wouldn't have to work too hard to make that one come true. Dr Albin: I love that. As a neurointensivist, I definitely feel that TBI prevention. We could talk about this all day long. I really wish we had a longer bit of time, but I really would direct all of our listeners to this fantastic article where you give really practical advice. And so again, today I've been interviewing Drs Daniel Correa and Rana Said about their article on bridging the gap between brain health guidelines and real-world implementation, written with Dr Justin Jordan. This article appears in the most recent issue of Continuum on the disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues. And thank you so much for our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. We hope you've enjoyed this subscriber-exclusive interview. Thank you for listening.

It's one thing to recognize red flags in your relationships. It's another thing to know what to do after that.In this episode, you'll learn:Five spectrums to consider when determining how serious a red flag is.Guidelines for determining if a particular red flag is something that needs to be confronted or self-managed.How to grow in awareness of red flags without getting overwhelmed or scared to get close to others.Links we mentioned in this episode:Download "Is This Normal? 15 Red Flags You May Be Missing in Your Relationships" by Lysa TerKeurst here.Sign up for a $10 webinar on September 4 at 7 p.m. ET with the Chosen team to learn about attachment styles and foster better communication with your children — no matter their age. Have a question for Lysa, Jim, or Joel? Leave us a message, and it could be answered on one of our future podcast episodes! Start here.Click here to download a transcript of this episode.Go deeper: Listen to "Red Flags We Shouldn't Ignore in Relationships."Listen to "Here Is Your Permission To Set Boundaries" With Jim Cress.Watch "Difficult vs. Destructive Relationships."

Kelly is referred to physical therapy six days after coronary artery bypass graft (CABG) surgery. She reports mild fatigue but denies chest pain or shortness of breath. Her resting heart rate is 85 bpm, and her blood pressure is 125/80 mmHg. The therapist plans to begin light aerobic exercise as part of her cardiac rehabilitation. Which of the following is the MOST appropriate guideline to follow during this session?A) Monitor for a target heart rate of 70–80% of her age-predicted maximumB) Avoid upper extremity exercises to minimize sternal stressC) Limit aerobic exercise to a maximum of 1–2 METs during this phaseD) Emphasize light aerobic exercise with an intensity below 13 on the Borg RPE scaleTEXT OUR TEAM:(727) 732-4573

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-442 Overview: Listen in as we review the USPSTF's recently proposed recommendations for screening women who are at risk for developing osteoporosis. Gain confidence to navigate these changes and engage patients in shared decision-making to ensure timely, evidence-based preventive care. Episode resource links: JAMA. 2025;333(6):498–508. doi:10.1001/jama.2024.27154 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Pain during a cesarean section isn't a new problem. But for a long time, it's been a hidden one. In England, a patient named Susanna not only brings the problem to doctors' attention, but also tries to solve it. To get full access to this show, and to other Serial Productions and New York Times podcasts on Apple Podcasts and Spotify, subscribe at nytimes.com/podcasts.To find out about new shows from Serial Productions, and get a look behind the scenes, sign up for our newsletter at nytimes.com/serialnewsletter.Have a story pitch, a tip, or feedback on our shows? Email us at serialshows@nytimes.com